IONIQ Sciences to Present at BioFuture
Salt Lake City, UT, October 24, 2022 – ProLung, Inc. dba IONIQ Sciences, Inc. (“IONIQ” or the...
Read More
IONIQ joins Cancer Early Detection Alliance
Salt Lake City, UT, September 8, 2022 – ProLung, Inc. dba IONIQ Sciences, Inc. (“IONIQ” or the...
Read More
IONIQ recognized as ‘Gamechanger 2022’ award winner
Salt Lake City, UT, August 10, 2022 – ProLung, Inc. dba IONIQ Sciences, Inc. (“IONIQ” or the...
Read More
IONIQ’s new LUNA3 is a Winner
Salt Lake City, UT, July 1, 2022 – ProLung, Inc. dba IONIQ Sciences, Inc. (“IONIQ” or the...
Read More
IONIQ Unveils LUNA3, Next-Generation Early-Stage Cancer Detection Platform
In News
Salt Lake City, UT, June 23, 2022 – ProLung, Inc. dba IONIQ Sciences, Inc. (“IONIQ” or the...
Read More
IONIQ Presents Lung Cancer Trial Results at ATS 2022
In News
Salt Lake City, UT, May 19, 2022 – IONIQ Sciences is proud of our team members who...
Read More
IONIQ Receives Three Awards including ‘Best Medical Technology Company 2022’
Salt Lake City, UT, May 10, 2022 – IONIQ Sciences is humbled to be recognized with three separate...
Read More
IONIQ hosts Salt Lake City Mayor Mendenhall at its Office
In News
Salt Lake City, UT, May 2, 2022 – IONIQ Sciences, Inc. (“IONIQ” or the “Company”) was honored...
Read More
IONIQ Sciences hires Edison Group as Investor Relations Advisor
In News
Salt Lake City, UT, March 17, 2022 – IONIQ Sciences, Inc. (“IONIQ” or the “Company”) announced today...
Read More
IONIQ Sciences announces IP acquisition and License buyout
In News
Salt Lake City, UT, March 8, 2022 – ProLung, Inc. dba IONIQ Sciences, Inc. (“IONIQ” or the...
Read More
IONIQ Sciences submits De Novo application to FDA for IONIQ ProLung Test
Salt Lake City, UT, February 2, 2022 – IONIQ Sciences, Inc. (“IONIQ” or the “Company”) announced today...
Read More
IONIQ Sciences is awarded “Best of Salt Lake City – Cancer Testing 2021”
Salt Lake City, UT, December 21, 2021 – IONIQ Sciences, Inc. (“IONIQ” or the “Company”) is honored...
Read More